2005 EXECUTIVE COMPENSATION PLANExecutive Compensation Plan Agreement |
|
|
You are currently viewing: This Executive Compensation Plan Agreement involves
NEKTAR THERAPEUTICS. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here. |
|
|
|
Search Executive Compensation Plan Agreement by:
Exhibit 10.1
2005 EXECUTIVE COMPENSATION PLAN
On March 15, 2005, the Board of Directors of Nektar Therapeutics (the “Company”), approved the following guidelines for the 2005 Executive Compensation Plan (the “Plan”).
COMPENSATION PHILOSOPHY
The primary goals of the Plan are to help drive the attainment of key business objectives while enabling the Company to attract, retain and reward capable executives who can contribute to the Company’s continued success. Equity participation and a strong alignment to stockholders’ interests are key elements of the Company’s compensation philosophy. Four key goals form the basis for compensation decisions for all executives:
|
|
1. |
To attract and retain the most highly qualified management and employee team; |
|
|
2. |
To emphasize sustained performance by aligning rewards with stockholder interests, especially through the use of equity participation programs; |
|
|
3. |
To pay competitively compared to similar drug delivery and biopharmaceutical companies and to provide appropriate reward opportunities for achieving high levels of performance with regards to business objectives and to similar organizations in the marketplace; and |
|
|
